All notes

3 min readAbout Variance

What we invest in at seed and pre-seed

The six sectors Variance Ventures backs at seed and pre-seed: autonomous systems, AI, biotechnology, software, health tech and interactive media.

By Variance Ventures

Variance Ventures invests at the earliest stages, seed and pre-seed, in founders building the foundational systems that will define the next era. We focus on six sectors.

We primarily focus on the US and consider founders globally. Our typical initial check is around $50k, with flexibility. Share your full financing plan alongside the amount you are seeking from us.

They have two things in common. Each is being reshaped by advances in computation. And in each, a company's advantage usually comes from technical depth that is hard to copy, rather than from distribution alone.

Autonomous systems

Intelligence without intermediaries. Systems that sense, decide and act without a person in the loop for every step: robotics, autonomous vehicles and drones, industrial automation, and software agents that complete work from start to finish.

We look for teams that understand the whole stack, from perception and control to deployment and safety, and for markets where autonomy changes the economics of the work rather than only the interface.

Read our autonomous systems investment focus, robotics investor guide, and robotics fundraising milestones.

Artificial intelligence

Building the cognitive infrastructure. Models are one layer. Around them sits everything needed to make them useful: data, training and inference systems, evaluation, developer tooling, and the applications that turn raw capability into reliable products.

We're most interested where a team has a lasting advantage: proprietary data, a technical approach that is hard to reproduce, or deep knowledge of the domain they're building for.

Read our AI investment focus, AI seed investor guide, and AI fundraising guide.

Biotechnology

The convergence of biology and computation. Biology is becoming more measurable and more programmable. We back companies where the two meet: computational drug discovery, protein and molecular design, synthetic biology, and the lab automation and data platforms that make experiments faster and more reproducible.

Read our biotechnology investment focus, biotech investor guide, and biotech fundraising milestones.

Software

Foundational tools for builders. Developer tools, infrastructure and platforms that other companies build on. Good tools compound, because every team that adopts them ships faster.

We look for products that engineers choose for themselves, built by founders who have felt the problem firsthand.

Read our software investment focus, software investor guide, and software adoption and fundraising guide.

Health technology

Extending human capability and longevity. Technology that helps people live longer and better: diagnostics, care delivery, medical devices, and the software that connects them.

Health is a demanding market, with regulation, reimbursement and long sales cycles. We look for teams with a credible plan for those realities, not just a strong product.

Read our health technology investment focus, healthtech investor guide, and healthtech pilot and commercial evidence guide.

Interactive media

AI-native creative experiences. New tools and formats for making and experiencing media: games, interactive storytelling, and generative tools for creators.

The most interesting work here is experiences that couldn't exist without AI, rather than familiar formats with AI added on.

Read our interactive media investment focus, gaming and interactive media investor guide, and interactive media fundraising guide.

Between the lines

The boundaries between these sectors are blurry, and some of the most ambitious companies sit across two or three of them: an autonomous lab is robotics and biotechnology, and a clinical AI system is health tech built on AI infrastructure.

If you're building in any of these areas, here's what to send us.